Genetic Risk-Based Atrial Fibrillation Screening (GeneAF Study)

Clinical trial NCT04932798 · UNKNOWN

Trial details

NCT number: NCT04932798
Sponsor: Montreal Heart Institute
Status: UNKNOWN
Study type: OBSERVATIONAL

Genetic Predisposition Atrial Fibrillation

Start date: 2021-06-01
Primary completion: 2026-01-10
Enrollment: 726

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.